Towards Healthcare
Intranasal Drug Delivery Devices Market to Rise at 10.04% CAGR till 2034

Intranasal Drug Delivery Devices Market Rising with Nanotech

According to forecasts, the global intranasal drug delivery devices market will grow from USD 1.74 billion in 2024 to USD 4.54 billion by 2034, with an expected CAGR of 10.04%. The intranasal drug delivery devices market is growing as it provides rapid drug onset, avoids first-pass metabolism, and is non-invasive to maximise patient comfort and compliance. North America is the dominant market due to the increasing prevalence of chronic conditions and the growing aging population.

  • Insight Code: 6187
  • No. of Pages:
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The intranasal drug delivery devices market stands at USD 1.91 billion in 2025 and is expected to reach USD 4.54 billion by 2034, growing at a CAGR of 10.04% from 2024 to 2034.

North America is currently leading the intranasal drug delivery devices market share 40% due to the presence of a regulatory environment and rapid economic growth.

Some key players include MetLife, Inc., Prudential Financial, Inc., Manulife Financial Corporation, Sun Life Financial, AIA Group Limited, and AXA S.A.

It is a lifetime comprehensive coverage that offers complete insurance. It pays out to your beneficiary at the point of the policyholder death. These are medical coverage and cover health needs.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.